Home › Funds › ORBIMED ADVISORS LLC › GH
ORBIMED ADVISORS LLC position in GH
GUARDANT HEALTH INC · Health Care
ORBIMED ADVISORS LLC reported holding 583,700 shares of GH (GUARDANT HEALTH INC) in its Q2 2026 13F filing — a position valued at US$87.6M, representing 1.76% of its reported portfolio and ranking #11 among its reported holdings. ORBIMED ADVISORS LLC has disclosed GH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's GH position evolved
ORBIMED ADVISORS LLC first disclosed a stake in GH in Q1 2026 at 435,200 shares (US$40.2M). The position peaked in Q2 2026 at 583,700 shares, worth US$87.6M. Across 2 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 583,700 shares valued at US$87.6M — an increase of 148,500 shares quarter over quarter.. Notable position changes include a 34% increase in Q2 2026 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 435.20K | $40.20M | New |
| Q2 2026 | 583.70K | $87.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GH and 13F data
GH (GUARDANT HEALTH INC) is a Health Care company. 57 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M), EVENTIDE ASSET MANAGEMENT, LLC (US$293.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GH
- Deep Track Capital, LP 3.39M sh · $509.10M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 2.63M sh · $394.43M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.96M sh · $293.79M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.62M sh · $243.72M · Q2 2026
- TWO SIGMA ADVISERS, LP 2.38M sh · $243.33M · Q4 2025
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.53M sh · $230.14M · Q2 2026
- RTW INVESTMENTS, LP 1.48M sh · $222.20M · Q2 2026
- Hood River Capital Management LLC 1.40M sh · $209.34M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.31M sh · $196.74M · Q2 2026
- Temasek Holdings (Private) Ltd 1.02M sh · $153.62M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 967.70K sh · $145.18M · Q2 2026
- CADIAN CAPITAL MANAGEMENT, LP 757.39K sh · $113.63M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held GH?
ORBIMED ADVISORS LLC has disclosed GH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is ORBIMED ADVISORS LLC's current position in GH?
As of Q2 2026, ORBIMED ADVISORS LLC holds 583.70K shares of GH (GUARDANT HEALTH INC), valued at $87.57M, representing 1.76% of its reported portfolio and ranking #11.
Has ORBIMED ADVISORS LLC been buying or selling GH?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in GH. The position peaked in Q2 2026 at 583.70K shares.
Which other funds hold GH?
Other major institutional holders of GH include Deep Track Capital, LP, FULLER & THALER ASSET MANAGEMENT, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.